ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,966Medicare Part D Prescriptions Filled, Including Refills

Rank: 363 out of 2588

$732K Total Retail Price of All Prescriptions

Rank: 204 out of 2588

423 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

9% of this provider’s 423 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

0% of this provider’s 8,803 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

40% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$73 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
LEVOTHYROXINE SODIUM 364 326 1 2
AMLODIPINE BESYLATE 341 304 2 4
SIMVASTATIN 309 273 3 1
OMEPRAZOLE 305 271 4 6
ATORVASTATIN CALCIUM 297 261 5 11
METOPROLOL SUCCINATE 244 195 6 12
FUROSEMIDE 223 202 7 5
WARFARIN SODIUM 217 205 8 10
ZOLPIDEM TARTRATE 214 187 9 24
DIOVAN 192 185 10 29
NEXIUM 184 162 11 41
BYSTOLIC 141 128 12 110
ALLOPURINOL 137 120 13 33
LOSARTAN POTASSIUM 136 130 14 17
CARVEDILOL 125 92 15 20
ZETIA 124 109 16 69
DONEPEZIL HCL 123 123 17 22
PLAVIX 122 105 18 43
PRAVASTATIN SODIUM 119 109 19 16
METFORMIN HCL 115 96 20 8
LIPITOR 115 113 20 114
CITALOPRAM HBR 114 108 22 27
METOPROLOL TARTRATE 108 95 23 9
ATENOLOL 105 96 24 14
CLOPIDOGREL 104 100 25 30
SYNTHROID 101 98 26 88
BENAZEPRIL HCL 99 81 27 84
ISOSORBIDE MONONITRATE ER 98 98 28 49
PREDNISONE 97 96 29 42
FLUTICASONE PROPIONATE 95 74 30 40
CYMBALTA 87 79 31 70
ESCITALOPRAM OXALATE 86 81 32 68
DIOVAN HCT 85 76 33 72
TRIAMTERENE-HCTZ 79 79 34 46
TRICOR 78 58 35 122
AMLODIPINE BESYLATE-BENAZEPRIL 78 76 35 76
HYDROCODONE-ACETAMINOPHEN 77 65 S3 37 7
GLIMEPIRIDE 76 60 38 39
LOVAZA 72 39 39 119
CRESTOR 72 72 39 25
LISINOPRIL 70 67 41 3
MIRTAZAPINE 68 60 42 63
HYDROCHLOROTHIAZIDE 68 60 42 13
NAMENDA 67 67 44 32
LIDODERM 65 55 45 86
GABAPENTIN 64 56 46 18
JANUVIA 63 48 47 60
BENICAR 62 50 48 143
RANITIDINE HCL 61 45 49 37
METFORMIN HCL ER 59 37 50 67
TRAMADOL HCL 58 51 51 19
DILTIAZEM ER 56 56 52 150
TAMSULOSIN HCL 56 44 52 23
LEXAPRO 55 41 54 182
POLYETHYLENE GLYCOL 3350 55 54 54 55
NIFEDIPINE ER 53 53 56 59
JANUMET 52 35 57 211
DIGOXIN 52 50 57 38
AZITHROMYCIN 51 48 59 45
INSULIN SYRINGE 50 35 60 81
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 26, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.